The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Open accessAbstract
Introduction: Severe sepsis and septic shock are common problems in the intensive care unit and carry a high mortality. Endotoxin, one of the principal components on the outer membrane of gram-negative bacteria, is considered important to their pathogenesis. Polymyxin B bound and immobilized to polystyrene fibers (PMX-F) is a medical device that aims to remove circulating endotoxin by adsorption, theoretically preventing the progression of the biological cascade of sepsis. We performed a systematic review to describe the effect in septic patients of direct hemoperfusion with PMX-F on outcomes of blood pressure, use of vasoactive drugs, oxygenation, and mortality reported in published studies. Methods: We searched PubMed, the Cochrane Collaboration Database, and bibliographies of retrieved articles and consulted with experts to identify relevant studies. Prospective and retrospective observational studies, pre- and post-intervention design, and randomized controlled trials were included. Three authors reviewed all citations. We identified a total of 28 publications – 9 randomized controlled trials, 7 non-randomized parallel studies, and 12 pre-post design studies – that reported at least one of the specified outcome measures (pooled sample size, 1,425 patients: 978 PMX-F and 447 conventional medical therapy). Results: Overall, mean arterial pressure (MAP) increased by 19 mm Hg (95% confidence interval [CI], 15 to 22 mm Hg; p < 0.001), representing a 26% mean increase in MAP (range, 14% to 42%), whereas dopamine/dobutamine dose decreased by 1.8 μg/kg per minute (95% CI, 0.4 to 3.3 μg/kg per minute; p = 0.01) after PMX-F. There was significant intertrial heterogeneity for these outcomes (p < 0.001), which became non-significant when analysis was stratified for baseline MAP. The mean arterial partial pressure of oxygen/fraction of inspired oxygen (PaO 2/FiO 2) ratio increased by 32 units (95% CI, 23 to 41 units; p < 0.001). PMX-F therapy was associated with significantly lower mortality risk (risk ratio, 0.53; 95% CI, 0.43 to 0.65). The trials assessed had suboptimal method quality. Conclusion: Based on this critical review of the published literature, direct hemoperfusion with PMX-F appears to have favorable effects on MAP, dopamine use, PaO 2/FiO 2 ratio, and mortality. However, publication bias and lack of blinding need to be considered. These findings support the need for further rigorous study of this therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.
Amato, M. B. P., Barbas, C. S. V., Medeiros, D. M., Magaldi, R. B., Schettino, G. P., Lorenzi-Filho, G., Kairalla, R. A., Deheinzelin, D., Munoz, C., Oliveira, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802053380602 · Cited by 3,654
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
(2012) · Hepatogastroenterology · doi:10.5754/hge12404 · Cited by 1,825
Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, R. P., Teng, N. N. H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240701 · Cited by 1,611
Variance imputation for overviews of clinical trials with continuous response
Follmann, D., Elliott, P., Suh, I., & Cutler, J. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90054-q · Cited by 1,385
Epidemiology of sepsis: an update
Angus, D. C., & Wax, R. S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00035 · Cited by 813
McCloskey, R. V., Straube, R. C., Sanders, C., Smith, S. M., Smith, C. R., & and CHESS Trial Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00001 · Cited by 495
Shoji, H. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00005.x · Cited by 370
Marshall, J. C., Foster, D., Vincent, J., Cook, D. J., Cohen, J., Dellinger, R. P., Opal, S., Abraham, E., Brett, S. J., Smith, T., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422254 · Cited by 365
Vincent, J.-L., Laterre, P.-F., Cohen, J., Burchardi, H., Bruining, H., Lerma, F. A., Wittebole, X., De Backer, D., Brett, S., Marzo, D., et al. (2005) · Shock · doi:10.1097/01.shk.0000159930.87737.8a · Cited by 297
Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-inimobilized fiber
Aoki, H., Kodama, M., Tani, T., & Hanasawa, K. (1994) · The American Journal of Surgery · doi:10.1016/0002-9610(94)90126-0 · Cited by 207
Newly Developed Immobilized Polymyxin B Fibers Improve the Survival of Patients with Sepsis
Nemoto, H., Nakamoto, H., Okada, H., Sugahara, S., Moriwaki, K., Arai, M., Kanno, Y., & Suzuki, H. (2001) · Blood Purification · doi:10.1159/000046966 · Cited by 118
Kushi, H., Miki, T., Okamaoto, K., Nakahara, J., Saito, T., & Tanjoh, K. (2005) · Critical Care · doi:10.1186/cc3815 · Cited by 110
Tani, T., Hanasawa, K., Kodama, M., Imaizumi, H., Yonekawa, M., Saito, M., Ikeda, T., Yagi, Y., Takayama, K., Amano, I., et al. (2001) · World Journal of Surgery · doi:10.1007/s002680020028 · Cited by 105
Tsushima, K., Kubo, K., Koizumi, T., Yamamoto, H., Fujimoto, K., Hora, K., & Kan‐nou, Y. (2002) · Journal of Clinical Apheresis · doi:10.1002/jca.10019 · Cited by 92
Nakamura, T., Ebihara, I., Shoji, H., Ushiyama, C., Suzuki, S., & Koide, H. (1999) · Inflammation Research · doi:10.1007/s000110050442 · Cited by 76
Uriu, K., Osajima, A., Hiroshige, K., Watanabe, H., Aibara, K., Inada, Y., Segawa, K., Anai, H., Takagi, I., Ito, A., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32767 · Cited by 73
Nakamura, T., Kawagoe, Y., Matsuda, T., Shoji, H., Ueda, Y., Tamura, N., Ebihara, I., & Koide, H. (2004) · Blood Purification · doi:10.1159/000078494 · Cited by 69
Suzuki, H., Nemoto, H., Nakamoto, H., Okada, H., Sugahara, S., Kanno, Y., & Moriwaki, K. (2002) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2002.00416.x · Cited by 65
Hattar, K., Grandel, U., Mœller, A., Fink, L., Iglhaut, J., Härtung, T., Morath, S., Seeger, W., Grimminger, F., & Sibelius, U. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202204.01230.44 · Cited by 58
Kojika, M., Sato, N., Yaegashi, Y., Suzuki, Y., SUZUKI, K. S., Nakae, H., & Endo, S. (2006) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2006.00340.x · Cited by 53
Novel therapies for sepsis: antiendotoxin therapies
Manocha, S., Feinstein, D., Kumar, A., & Kumar, A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1795 · Cited by 49
Nakamura, T., Ebihara, I., Shimada, N., & Koide, H. (1998) · Intensive Care Medicine · doi:10.1007/s001340050761 · Cited by 43
Nakamura, T., Ushiyama, C., Suzuki, Y., Inoue, T., Shoji, H., Shimada, N., & Koide, H. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1332 · Cited by 37
The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis.
Ronco, C. (2005) · Critical Care · doi:10.1186/cc3890 · Cited by 31
Self-citationNakamura, T., Ushiyama, C., Suzuki, Y., Shoji, H., Shimada, N., & Koide, H. (2002) · ASAIO Journal · doi:10.1097/00002480-200205000-00008 · Cited by 27
Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis
Nakamura, T., Kawagoe, Y., Matsuda, T., & Koide, H. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2357-7 · Cited by 25
Nakamura, T., Ushiyama, C., Suzuki, Y., Osada, S., Inoue, T., Shoji, H., Hara, M., Shimada, N., & Koide, H. (2003) · Nephron Clinical Practice · doi:10.1159/000071279 · Cited by 25
Nakamura, T., Kawagoe, Y., Suzuki, T., Shoji, H., Ueda, Y., Kobayashi, N., & Koide, H. (2005) · Blood Purification · doi:10.1159/000088016 · Cited by 22
Tojimbara, T., Sato, S., Nakajima, I., Fuchinoue, S., Akiba, T., & Teraoka, S. (2004) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1526-0968.2004.00166.x · Cited by 17
Uriu, K., Osajima, A., Kamochi, M., Watanabe, H., Aibara, K., & Kaizu, K. (2001) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2001.005001025.x · Cited by 17
Cited by
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Sepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Cruz, D. N., Antonelli, M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., Malcangi, V., Petrini, F., Volta, G., Bobbio Pallavicini, F. M., et al. (2009) · JAMA · doi:10.1001/jama.2009.856 · Cited by 832
Self-citationGan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
The ABDOMIX Group, Payen, D. M., Guilhot, J., Launey, Y., Lukaszewicz, A. C., Kaaki, M., Veber, B., Pottecher, J., Joannes-Boyau, O., Martin-Lefevre, L., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3751-z · Cited by 407
Metadata
- Authors
- Cruz, D. N., Perazella, M. A., Bellomo, R., de Cal, M., Polanco, N., Corradi, V., Lentini, P., Nalesso, F., Ueno, T., Ranieri, V. M., & Ronco, C.
- Venue
- Critical Care
- Published
- 2007-04-20
- Volume
- 11
- Issue
- 2
- Pages
- R47-R47
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2123255995
- Cited by
- 347
- References
- 37
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.